Fifth Third Bancorp Genmab A/S Transaction History

Fifth Third Bancorp

$28.3 Billion
Q2 2025

A detailed history of Fifth Third Bancorp transactions in Genmab A/S stock. As of the latest transaction made, Fifth Third Bancorp holds 41,425 shares of GMAB stock, worth $1.38 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

41,425

Previous 42,151 1.72%

Holding current value

$1.38 Million

Previous $825,000 3.64%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 15, 2025	SELL	$17.98 - $23.09 $13,053 - $16,763	-726 Reduced 1.72%	41,425 $855,000
Q1 2025 Apr 15, 2025	BUY	$18.69 - $24.14 $112,420 - $145,202	6,015 Added 16.65%	42,151 $825,000
Q4 2024 Jan 21, 2025	SELL	$20.02 - $24.15 $168,968 - $203,826	-8,440 Reduced 18.93%	36,136 $754,000
Q3 2024 Oct 17, 2024	SELL	$23.84 - $28.48 $16,211 - $19,366	-680 Reduced 1.5%	44,576 $1.09 Million
Q2 2024 Jul 22, 2024	SELL	$25.13 - $30.27 $108,812 - $131,069	-4,330 Reduced 8.73%	45,256 $1.14 Million
Q1 2024 Apr 23, 2024	SELL	$26.43 - $32.77 $9,461 - $11,731	-358 Reduced 0.72%	49,586 $1.48 Million
Q4 2023 Jan 19, 2024	SELL	$27.94 - $35.44 $56,662 - $71,872	-2,028 Reduced 3.9%	49,944 $1.59 Million
Q3 2023 Oct 31, 2023	BUY	$35.27 - $42.24 $1.83 Million - $2.19 Million	51,751 Added 23416.74%	51,972 $1.83 Million
Q1 2023 Apr 24, 2023	BUY	$34.88 - $43.22 $348 - $432	10 Added 4.74%	221 $8,000
Q4 2022 Jan 25, 2023	SELL	$33.8 - $47.06 $1,013 - $1,411	-30 Reduced 12.45%	211 $0
Q3 2022 Oct 25, 2022	SELL	$31.52 - $373.61 $409 - $4,856	-13 Reduced 5.12%	241 $8,000
Q2 2022 Aug 04, 2022	BUY	$26.83 - $38.57 $1,797 - $2,584	67 Added 35.83%	254 $8,000
Q1 2022 Apr 19, 2022	SELL	$30.95 - $39.68 $5,478 - $7,023	-177 Reduced 48.63%	187 $7,000
Q3 2021 Oct 15, 2021	BUY	$41.55 - $48.72 $997 - $1,169	24 Added 7.06%	364 $16,000
Q1 2021 May 07, 2021	SELL	$30.92 - $44.4 $21,272 - $30,547	-688 Reduced 66.93%	340 $11,000
Q4 2020 Feb 16, 2021	BUY	$33.66 - $40.76 $16,156 - $19,564	480 Added 87.59%	1,028 $42,000
Q2 2020 Aug 05, 2020	BUY	$20.05 - $33.89 $3,749 - $6,337	187 Added 51.8%	548 $19,000
Q4 2019 Feb 14, 2020	BUY	$18.88 - $24.14 $6,815 - $8,714	361 New	361 $8,000

Others Institutions Holding GMAB

# of Institutions

242

Shares Held

65.1M

Call Options Held

32.5K

Put Options Held

55K

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $21.9B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.

Account

Fifth Third Bancorp Genmab A/S Transaction History